15-47757579-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001358352.2(SEMA6D):​c.-54-2166C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.493 in 151,884 control chromosomes in the GnomAD database, including 21,375 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 21375 hom., cov: 32)

Consequence

SEMA6D
NM_001358352.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.612

Publications

0 publications found
Variant links:
Genes affected
SEMA6D (HGNC:16770): (semaphorin 6D) Semaphorins are a large family, including both secreted and membrane associated proteins, many of which have been implicated as inhibitors or chemorepellents in axon pathfinding, fasciculation and branching, and target selection. All semaphorins possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Additional sequence motifs C-terminal to the semaphorin domain allow classification into distinct subfamilies. Results demonstrate that transmembrane semaphorins, like the secreted ones, can act as repulsive axon guidance cues. This gene encodes a class 6 vertebrate transmembrane semaphorin that demonstrates alternative splicing. Several transcript variants have been identified and expression of the distinct encoded isoforms is thought to be regulated in a tissue- and development-dependent manner. [provided by RefSeq, Nov 2010]
SEMA6D Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.769 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001358352.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEMA6D
NM_001358351.3
MANE Select
c.-54-2166C>T
intron
N/ANP_001345280.1
SEMA6D
NM_001358352.2
c.-54-2166C>T
intron
N/ANP_001345281.1
SEMA6D
NM_153618.2
c.-54-2166C>T
intron
N/ANP_705871.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEMA6D
ENST00000536845.7
TSL:2 MANE Select
c.-54-2166C>T
intron
N/AENSP00000446152.3
SEMA6D
ENST00000316364.9
TSL:1
c.-54-2166C>T
intron
N/AENSP00000324857.5
SEMA6D
ENST00000354744.8
TSL:1
c.-54-2166C>T
intron
N/AENSP00000346786.4

Frequencies

GnomAD3 genomes
AF:
0.492
AC:
74737
AN:
151766
Hom.:
21316
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.776
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.313
Gnomad EAS
AF:
0.711
Gnomad SAS
AF:
0.531
Gnomad FIN
AF:
0.431
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.332
Gnomad OTH
AF:
0.458
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.493
AC:
74863
AN:
151884
Hom.:
21375
Cov.:
32
AF XY:
0.499
AC XY:
37056
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.776
AC:
32188
AN:
41456
American (AMR)
AF:
0.448
AC:
6841
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
1086
AN:
3466
East Asian (EAS)
AF:
0.710
AC:
3658
AN:
5150
South Asian (SAS)
AF:
0.529
AC:
2547
AN:
4814
European-Finnish (FIN)
AF:
0.431
AC:
4529
AN:
10514
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.332
AC:
22551
AN:
67908
Other (OTH)
AF:
0.464
AC:
980
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1675
3351
5026
6702
8377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.202
Hom.:
362
Bravo
AF:
0.508
Asia WGS
AF:
0.656
AC:
2278
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.88
DANN
Benign
0.51
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs586118; hg19: chr15-48049776; API